RAP Discussion 2022
- Thread starter zeeb0t
- Start date
Dhm
Regular
How long have you got? 
Highlights:
Disruptive technology coming out of UQ
Gates Foundation seeding
Take-up of Dx by Medgate and Alodokter with resultant revenue.
Collaboration with other entities like AstraZeneca and Janssen
TGA and CE Mark as a Class 2 DIAGNOSTIC tool.
ENORMOUS potential globally especially in the Telehealth respiratory diagnostic area.
Lowlights:
Two stuffups in US Clinical trials - although technically the second wasn't ResApp's fault.
FDA knock back of Dx (very painful)
Very slow take-up in telehealth sphere.
Sleepcheck. Whilst a good product it seems dead in the water (also very painful)
Questionable senior management.
Market just doesn't seem to get the ResApp tech.
Short term potential turnarounds:
Imminent results of pilot trials to detect and diagnose Covid from a forced cough.
Rescheduling of FDA for re assessment of ResApp-Dx this year.
FDA assessmsnt of Sleepcheck.
Further signing with telehealth providers, especially in Asia, but quite frankly I'll take anywhere.
Highlights:
Disruptive technology coming out of UQ
Gates Foundation seeding
Take-up of Dx by Medgate and Alodokter with resultant revenue.
Collaboration with other entities like AstraZeneca and Janssen
TGA and CE Mark as a Class 2 DIAGNOSTIC tool.
ENORMOUS potential globally especially in the Telehealth respiratory diagnostic area.
Lowlights:
Two stuffups in US Clinical trials - although technically the second wasn't ResApp's fault.
FDA knock back of Dx (very painful)
Very slow take-up in telehealth sphere.
Sleepcheck. Whilst a good product it seems dead in the water (also very painful)
Questionable senior management.
Market just doesn't seem to get the ResApp tech.
Short term potential turnarounds:
Imminent results of pilot trials to detect and diagnose Covid from a forced cough.
Rescheduling of FDA for re assessment of ResApp-Dx this year.
FDA assessmsnt of Sleepcheck.
Further signing with telehealth providers, especially in Asia, but quite frankly I'll take anywhere.
Similar threads
